CSPCY OTC
CSPC Pharmaceutical Group Limited
1W: +7.1%
1M: +9.9%
3M: +21.7%
YTD: +17.8%
1Y: +8.3%
3Y: +91.7%
5Y: +23.5%
$5.10
+0.40 (+8.51%)
Weekly Expected Move ±9.5%
$4
$5
$5
$6
$6
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$4.5B
+8.5% ▲
5Y CAGR: +3.7%
Capital Expenditures
$2.7B
-41.5% ▼
5Y CAGR: +2.2%
Free Cash Flow
$1.9B
-18.8% ▼
5Y CAGR: -1.3%
Dividends Paid
$3.4B
-14.7% ▼
Buybacks
$2.3B
-1066.0% ▼
Net Change in Cash
-$4.6B
-283.7% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $6.1B | $6.8B | $6.1B | $7.4B | $4.6B |
| Depreciation & Amort. | $809M | $865M | $1.0B | $1.1B | $1.3B |
| Stock-Based Comp. | $9M | $18M | $141M | $259M | $210M |
| Change in Working Capital | $1.2B | -$2.0B | $352M | -$2.7B | -$206M |
| Other Non-Cash Items | -$1.5B | -$1.1B | -$5M | -$1.8B | -$1.4B |
| Operating Cash Flow | $6.7B | $4.6B | $7.6B | $4.2B | $4.5B |
| — Investing Activities — | |||||
| Capital Expenditures | -$1.6B | -$1.4B | -$2.5B | -$1.8B | -$2.1B |
| Acquisitions (Net) | -$471M | $40M | -$387M | $0 | -$173M |
| Investment Purchases | -$4.3B | -$6.5B | -$7.3B | -$4.7B | -$4.4B |
| Investment Sales | $4.1B | $7.3B | $3.4B | $6.7B | $3.0B |
| Other Investing | $25M | -$18M | -$32M | $366M | -$124M |
| Investing Cash Flow | -$2.1B | -$637M | -$6.8B | $607M | -$3.9B |
| — Financing Activities — | |||||
| Net Debt Issuance | -$110M | -$99M | -$10M | -$28M | $19M |
| Stock Repurchased | $0 | -$264M | -$14M | -$200M | -$2.3B |
| Dividends Paid | -$1.5B | -$2.1B | -$2.1B | -$3.0B | -$3.4B |
| Other Financing | $166M | $240M | $217M | $926M | $505M |
| Financing Cash Flow | -$1.5B | -$2.2B | -$1.9B | -$2.3B | -$5.3B |
| Net Change in Cash | $3.1B | $1.8B | -$1.1B | $2.5B | -$4.6B |
| Cash End of Period | $8.7B | $11.1B | $8.0B | $10.5B | $6.3B |
| Free Cash Flow | $6.4B | $2.9B | $4.9B | $2.3B | $1.9B |